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Background: Hyl from Streptococcus pneumoniae degrades host hyaluronan, an important polysaccharide component of
the mammalian extracellular matrix.
Results:Hyl has a hyaluronan-specific carbohydrate-bindingmodule, an extended conformation, and a propensity to dimerize.
Conclusion: Hyl both binds and degrades hyaluronan, which is facilitated by its cell surface presentation.
Significance: This is the first structural and functional characterization of a glycosaminoglycan-specific carbohydrate-binding
module.
For a subset of pathogenic microorganisms, including Strep-
tococcus pneumoniae, the recognition and degradation of host
hyaluronan contributes to bacterial spreading through the
extracellular matrix and enhancing access to host cell surfaces.
The hyaluronate lyase (Hyl) presented on the surface of S. pneu-
moniae performs this role. Using glycan microarray screening,
affinity electrophoresis, and isothermal titration calorimetrywe
show that theN-terminalmodule ofHyl is a hyaluronan-specific
carbohydrate-binding module (CBM) and the founding mem-
ber of CBM family 70. The 1.2 Å resolution x-ray crystal struc-
ture of CBM70 revealed it to have a -sandwich fold, similar to
other CBMs. The electrostatic properties of the binding site,
which was identified by site-directed mutagenesis, are distinct
from other CBMs and complementary to its acidic ligand, hya-
luronan.Dynamic light scattering and solution small angle x-ray
scattering revealed the full-length Hyl protein to exist as a
monomer/dimermixture in solution. Through a detailed analy-
sis of the small angle x-ray scattering data, we report the pseu-
doatomic solution structures of the monomer and dimer forms
of the full-length multimodular Hyl.
Hyaluronic acid, or hyaluronan, is a linear polysaccharide
composed of repeating disaccharide units of D-glucuronic acid
and D-N-acetylglucosamine linked by alternating -1,4 and
-1,3 glycosidic bonds. As a principal component of the extra-
cellular matrix, this comparatively simple, non-sulfated glyco-
saminoglycan is widely distributed throughout connective, epi-
thelial, and neural tissues. Hyaluronan plays an integral role in
mediatingamultitudeof interactions inkeybiological events, such
as wound healing, fertilization, cancer cell growth andmetastasis,
immune signal propagation, and as a shock-absorbing component
of synovial fluid (reviewed by Jiang et al. (1)).
Because of its ubiquitous presence as an extracellular matrix
component, hyaluronan recognition and processing is an impor-
tant intersection between various pathogens and animal hosts, as
is the case with Streptococcus pneumoniae. This bacterium is a
common commensal that colonizes the nasopharynx of40% of
humans without causing any adverse symptoms. S. pneu-
moniae, however, also possesses a potent capability for invasive
infection, causing a broad spectrum of diseases ranging from
common ear infections (otitis media) to more lethal infections,
such as acute respiratory disease, bacteremia, and meningitis
(2). The interaction of S. pneumoniae with its host is highly
complex, involving a number of elements (2), but one of the
earliest known factors is a hyaluronate-degrading enzyme (3, 4),
whose activity is highly correlated with invasive S. pneumoniae
infections (5, 6). Subsequent identification of the hyl gene
encoding this enzyme (7), Hyl, has promoted detailed study of
its contribution to virulence. In animal models, the direct con-
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tribution of Hyl to virulence is not significant; however, the
production of Hyl by the bacterium has a strong potentiating
effect on the critical virulence factor pneumolysin, a pore-
forming cytotoxin that binds to host cholesterol (8, 9). This
potentiating effect is consistentwithHyl playing a role in break-
ing the integrity of the extracellularmatrix barrier, thereby pro-
viding improved access of the bacterium and pneumolysin to
the host cell surface. In addition to the “spreading” action of
Hyl, this protein provides the bacterium with the capability of
using hyaluronan as a carbon source, which is linked to coloni-
zation and persistence of the bacterium (10). Given the capabil-
ity of Hyl to degrade the hyaluronan capsules of other poten-
tially competing bacteria, such as Streptococcus pyogenes, Hyl
may also play a niche-specific role in bacterial warfare (10).
Hyl is a 1066-amino acid protein that is anchored to the bac-
terial cell surface through a sortase-mediated process, although
soluble Hyl can also be found (11). A catalytically active frag-
ment of Hyl comprising amino acids300–1020 has been well
characterized both structurally and functionally (for examples,
see Refs. 11 and 12). By amino acid sequence identity, this
region of Hyl classifies it as a family 8 polysaccharide lyase
(PL8)5 (13). The PL8 domain of Hyl comprises a (/)6 barrel
(-domain) fused to an anti-parallel-sheet (-domain) that caps
the active site in the (/)6 barrel. This catalytically active PL8
domain enables Hyl to cleave hyaluronan using a -elimination
reactionmechanism, thus releasing a disaccharide product with a
4,5-unsaturated non-reducing end D-glucuronic acid.
The N-terminal region of Hyl remains uncharacterized.
Through the results of bioinformatics approaches, the amino
acids from roughly position 50 to 210 in Hyl were proposed to
comprise a carbohydrate-binding module (CBM) (14). CBMs are
common ancillary modules in carbohydrate-active enzymes,
where they function to target andhold the parent enzyme in prox-
imity to substrates, thereby enhancing enzyme efficiency (15).
Like carbohydrate-active enzyme catalytic modules, CBMs are
classified into amino acid sequence-based families (13). The
binding specificity of CBMs most commonly matches that of
the appended catalytic module (15). Indeed, Rigden and
Jedrzejas (14) hypothesized that the N-terminal domain of Hyl
is a hyaluronan-binding CBM that is similar in structure to the
-glycan binding family 4 CBMs.
Although the structures of several hyaluronan-specific
adherins (hyaladherins) have been determined, they are all of
eukaryotic origin and are involved in normal “self-recognition”
of hyaluronan in the extracellular matrix (16–18). At present,
there is comparatively little information regarding the molecu-
lar recognition of hyaluronan by pathogenic microbes. To
address this knowledge gap and test the hypothesis that the
N-terminal module of Hyl is a hyaluronan-specific CBM, we
examined the structural and functional properties of this module
using a combination of approaches, including glycan microarray,
isothermal titration calorimetry, x-ray crystallography, and site-
directed mutagenesis. Furthermore, we studied full-length Hyl
using solution small angle x-ray scattering (SAXS) to reveal the
first complete experimentally based model of the Hyl confor-
mation. The results reveal that Hyl possesses an N-terminal
hyaluronan-bindingCBM that is the foundingmember of CBM
family 70. The full-length protein adopts an extended confor-
mation and dimerizes in solution. The SAXS-based model of
Hyl, interpreted on the basis of its surface presentation, sug-
gests a conformation optimized for the interaction of the CBM
with hyaluronan present in the extracellular matrix.
EXPERIMENTAL PROCEDURES
Cloning—The oligonucleotide PCR primers used for the
amplification of the following constructs from genomic DNA
are presented in Table 1. Gene fragments encoding SpCBM70
(residues Lys53–Ser212) and a construct including the CBM,
middle, and PL8 domains of Hyl (residues Lys53–Lys1006; here-
after referred to as simply Hyl) were cloned via standard PCR,
restriction endonuclease, and ligation procedures into the plas-
mid pET28 (EMD Millipore), using NdeI and HindIII sites to
yield pSpCBM70 and pSpHyl expression vectors, respectively.
The gene fragment encoding the PL8 catalytic domain (resi-
dues Lys288–Gln1009) was cloned intopET28, using the In-Fusion
5 The abbreviations used are: PL8, polysaccharide lyase family 8 (as per CAZy
classification); CBM, carbohydrate-binding module; DLS, dynamic light
scattering; GAG, glycosaminoglycan; GH98, glycoside hydrolase family 98,
glycogen-degrading endo--galactosidase; Hyl, hyaluronate lyase; ITC,
isothermal titration calorimetry; NGL, neoglycolipid; SAXS, small angle
x-ray scattering; SSRL, Stanford Synchrotron Radiation Lightsource; Dmax,
maximum particle size; Rg, radii of gyration.
TABLE 1
Oligonucleotide primers
Oligonucleotide Primer sequence (5–3) Used to amplify and clone
N-CBM-for GGCATATGCCATGGAAAATTTAGTTGAAAATGGTG Hyl, SpCBM70
N-CBM-rev TTTTGAAGCTTTTAAGAAAGCTGGTCTGC SpCBM70
C-CBM-for GTGGTGCTCGAGTTAGCTTTTGATGAACGAAATG SpCBM70C, CBMmutants
C-CBM-rev CCAAGCTTGCGGCCGCAGAAAGCTGGTCTGC SpCBM70C, CBMmutants
Hyl-rev TTTTGAAGCTTTTACTTTTTAAAGACTTCC Hyl
W82A-for CAGGGGTGGTCAGCTGCGGTAGACCAGAAGAA W82A
W82A-rev ATTCTTCTGGTCTACCGCAGCTGACCACCCCTG W82A
R112A-for AGCCATGAGAAATTAGCGGCAGCGCTTCACCGT R112A
R112A-rev ACGGTGAAGCGCTGCCGCAATTTTCTCATGGCT R112A
H116A-for TTAAGGGCAGCGCTTGCGCGTATGGTTCCTATT H116A
H116A-rev AATAGGAACCATACGCGCAAGCGCTGCCCTTAA H116A
K143A-for AAAATCGGGATTGCCGCGGTTCGTATCATTGAG K143A
K143A-rev CTCAATGATACGAACCGCGGCAATCCCGATTTT K143A
R145A-for GGGATTGCCAAAGTTGCGATCATTGAGGAAAGT R145A
R145A-rev ACTTTCCTCAATGATCGCAACTTTGGCAATCCC R145A
K185A-for GATGTTGATAAAATCGCGCTGGAGTTATTCTAT K185A
K185A-rev ATAGAATAACTCCAGCGCGATTTTATCAACATC K185A
PL8-for CAGCCATATGGCTAGCAAGGATGCATACACAGACC PL8
PL8-rev GGTGGTGGTGCTCGAGTTATTGCTCTAGCTTTTTAAAGAC PL8
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HD cloning procedure (Clontech). All of the constructs above
encoded the desired polypeptides fused to an N-terminal six-his-
tidine tag by a thrombin cleavage site. An additional SpCBM70
construct (SpCBM70-C) encompassing residues Asn54–Ser212
was cloned into pET28 using NotI and NcoI sites to yield
pSpCBM70-C, which encoded SpCBM70 with a C-terminal six-
histidine tag.SpCBM70-Cmutants (W82A,R112A,H116A,K143A,
R145A, and K185A) were generated from the SpCBM70-C con-
struct using standard PCRmutagenesis procedures.
Protein Production and Purification—In all cases, recombi-
nant proteins were produced via the autoinduction method
(19), using shaking 1-liter cultures supplementedwith kanamy-
cin (50 g/ml) for 36 h at 37 °C, reducing the temperature to
16 °C, and continuing growth for an additional 48 h. Cells were
harvested by centrifugation anddisrupted by a lysozyme/chem-
ical lysis method using the sucrose-deoxycholate procedure, all
buffered with PBS (50 mM Na2HPO4, 300 mM NaCl, pH 7.5)
throughout. Briefly, pelleted cells were resuspended in 25ml of
25% sucrose-PBS. 10 mg of lysozyme was added while stirring,
followed by a 10-min incubation at 20 °C. 50 ml of a mixture of
1% deoxycholate, 1% Triton X-100-PBS was subsequently
added at 4 °C, and the mixture was stirred for 10 min. DNase
was added to 2 g/ml, and MgCl2 was added to 5 mM, and the
mixture was stirred at 20 °C for 15 min. Clarified lysates were
purified via immobilized metal affinity chromatography and
anion exchange chromatography. Proteins in 20 mM Tris-
HCl (pH 8.0) and 100 mM NaCl were concentrated using a
stirred ultrafiltration cell with a 10,000 molecular weight
cut-off filter. Protein concentrations were determined by
measuring absorbance at 280 nm (A280) and using calculated
molar extinction coefficients of 26,470 and 162,040 cm/M for
SpCBM70W82A and Hyl, respectively, 127,909 cm/M for
PL8, and 31970 cm/M for SpCBM70, SpCBM70-C, and the
remaining SpCBM70 mutants (20).
GlycanMicroarray Analyses—The glycan binding specificity
of SpCBM70was first analyzed using theGlycosciences Screen-
ing Array Set 32–39, comprising 492 lipid-linked oligosaccha-
ride probes of neoglycolipids (NGLs) or glycosylceramides (see
supplemental Table 1) (21).
Additionalanalysiswasperformedusingafocusedglycosamino-
glycan (GAG)microarray of 25 GAG oligosaccharide probes pre-
paredasNGLs(supplementalTable2).TheGAGoligosaccharides
were obtained by partial depolymerization of the polysaccharides
using lyases andsize-fractionatedbygel filtrationchromatography
as described (22). The oligosaccharide fractions were analyzed by
negative ion electrospray ionizationmass spectrometry after con-
version into their ammonium salts for determination of the chain
lengths of themajor components in the fractions. For arraying, the
oligosaccharides were converted into NGLs by reductive amina-
tion for chondroitin sulfate andhyaluronic acid andbyoxime liga-
tion for heparan sulfate andheparin oligosaccharides (23, 24). The
NGLprobeswerepurified, analyzed, andquantifiedbefore roboti-
cally printing onto nitrocellulose-coated 16-pad glass slides at 2
and 7 fmol/spot in duplicate.
For microarray binding analyses, the arrayed slides were
blocked with 3% (w/v) bovine serum albumin (BSA; Sigma-
Aldrich) in 5 mM HEPES buffer, pH 7.4, containing 150 mM
NaCl, 5 mM CaCl2 and overlaid for 1.5 h at ambient tempera-
ture with SpCBM70 precomplexed with mouse monoclonal
anti-polyhistidine (Ab1) and biotinylated anti-mouse IgG anti-
bodies (Ab2) (both from Sigma) in a ratio of 1:3:3 (by weight).
The complex was prepared by preincubating Ab1 with Ab2 for
15 min at ambient temperature, followed by the addition of
SpCBM70 and incubation for a further 15 min. The complex
was diluted with 1% BSA (w/v) to give a final SpCBM70 concen-
tration of 10 g/ml for overlaying. Carbohydrate binding was
detected with Alexa Fluor 647-labeled streptavidin. Data analysis
was performed with dedicatedmicroarray software (25).
Isothermal Titration Calorimetry—Isothermal titration calo-
rimetry (ITC) was performed using a VP-ITC (MicroCal,
Northampton, MA) at 25 °C in each case. Due to the viscosity
associated with concentrated hyaluronan solutions, concen-
trated SpCBM70 was titrated into hyaluronan solutions.
Briefly, SpCBM70 was extensively dialyzed against 25mMTris-
HCl (pH 7.5) and 50 mM NaCl and concentrated as described
above. Dialysate was retained and subsequently used for disso-
lution or dilution of reagents. In each case, protein and carbo-
hydrate solutionswere degassed immediately prior to use. Sam-
ples of 2.65 mM solution of SpCBM70 were titrated into a
solution of 0.142mg/ml hyaluronan (corresponding to an equiv-
alent concentration of 125M of a 6-mer fragment). Heat of dilu-
tion correcteddatawere fit to aone-site bindingmodel to yield the
association constant (Ka), change in enthalpy (H), and stoichi-
ometry (n). The change inGibb’s free energy (G) and the change
in entropy (S) were calculated from these values.
Purified fragments of hyaluronan of defined length (Oligo-4,
nanoHATM5, Oligo-6, and nanoHATM7, all from Sigma-Al-
drich) were titrated into SpCBM70 (150 M) under condi-
tions maintained such thatC values were in excess of 5. Heat of
dilution corrected data were fit to a one-site binding model to
yield the binding parameters.
Affinity Gel Electrophoresis—The interaction of SpCBM70-C
andmutantswith hyaluronanwas analyzed by affinity electropho-
resis. 9% (w/v) polyacrylamide gels (pH 8.8), were polymerized
with varying concentrations of hyaluronan (Sigma-Aldrich) rang-
ing from 0 to 0.045% final concentration. SpCBM70-C, the six
mutants, and three non-interacting control proteins were all run
for 3.5 h at a constant voltage of 150 V in an ice bath. Gels were
stainedwithCoomassieBrilliantBlueR-250.Affinitiesweredeter-
mined as described previously (26) and expressed as relative affin-
ities with the assumption of identical stoichiometries for all of the
proteins binding to the polysaccharide.
SpCBM70 Crystallization and Structure Determination—
SpCBM70-C supplemented with a 2-fold molar excess of hya-
luronan tetrasaccharide crystallized at a concentration of 20
mg/ml by the sitting drop vapor diffusion method by mixing
equal amounts of the protein solution with a mother liquor
consisting of 18% (w/v) polyethylene glycol 3,350 and 0.1 M
sodium acetate (pH 5.5) at 292 K. Hexagonal plate-shaped crys-
tals developed after 1 day and were subsequently cryopro-
tected with 25% ethylene glycol prior to diffraction experi-
ments. A bromide derivative data set was obtained by soaking
an SpCBM70 crystal for 5 min in crystallization solution sup-
plemented with 1 M NaBr prior to cryoprotection and freezing.
Diffraction data from the bromide derivative and native crys-
tals were both collected at the beamline 08B1-1 at the Canadian
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Macromolecular Crystallography Facility (Canadian Light
Source) using 0.5º oscillations. Data sets were processed with
XDS and scaled with Scala (27, 28). Bromide sites for phasing
were identified with ShelxC/D, and initial phasing was per-
formedwith ShelxE (29). The resulting phaseswere of sufficient
quality for a nearly complete model to be automatically built
with ARP/wARP (30). This model was subsequently used as a
startingmodel for the native structure.Model buildingwas per-
formed with Coot, and refinement was performed with Refmac
(31, 32). The final refinement incorporated the addition of
hydrogen in the riding positions and anisotropic B-factors.
Structure validation was performed withMolprobity (33). Data
collection, processing, and refinement statistics are presented
in Table 2. Figures were generated using PyMOL.
Small Angle X-ray Scattering—After a purification step of
size exclusion chromatography and filtering through a 0.22-m
filter, Hyl samples were examined by dynamic light scattering
(DLS). DLS data were collected at 25 °C in triplicate, averaging
15 acquisitions of 5 s using a DynaPro plate reader (Wyatt
Technology, Santa Barbara, CA). The data were then analyzed
using theDynamics version 7.1 software. Themolecular weight
was determined based on a globular protein model.
Synchrotron x-ray scattering data from purified solutions of
Hyl in 50 mM Tris-HCl (pH 8.0) and 500 mM NaCl at concen-
trations ranging from1.0 to 10.8mg/mlwere collected at beam-
line 4-2 at the Stanford Synchrotron Radiation Lightsource
(SSRL) using a MarCCD 165 detector. A solution (1 mg/ml) of
bovine serum albumin was measured as a reference and for
calibration purposes. Diffraction data were measured with an
exposure time of 1 min at 288 K with a wavelength of 1.50 Å.
The sample-to-detector distance was set at 2.5 m, leading to
scattering vectors q (defined as q  4/sin, where 2 is the
scattering angle) ranging from0.06 to 0.5 Å1. SAXS data proc-
essing and determination of the radii of gyration (Rg), andmax-
imum particle size (Dmax) were performed in accordance with
procedures described previously (34). The ab initio low resolu-
tion envelopes ofHyl were generatedwithDAMMIF (35), using
10 independent runs with no shape constraints. The solutions
were then aligned and averaged using the DAMAVER suite of
programs (36), which also computes the NSD values for the
groups of ab initiomodels (37).
The rigid body modeling of Hyl was performed with
SASREF7MX (38) using the structures of the three domains
comprising SpCBM70 (residues Lys53–Ser212), the linker domain
(residues Glu213–Val287, modeled based on the linker portion of
the Streptococcus agalactiae hyaluronate lyase, PDB entry 1I8Q),
and PL8 catalytic domain (residues Lys288–Lys1006, PDB entry
1LXK) (39) as separate rigid bodies. Maximum interdomain dis-
tances approximating the short amino acid linkers betweenNand
C termini were used as constraints, and P2 symmetry was used to
model the monomer and dimer mixture observed in solution.
The volumes of associated fractions were determined using
SASREF7MX as well as the OLIGOMER program (40, 41).
RESULTS
The N Terminus of Hyl Is a Hyaluronan-binding Module—
Thehyaluronan-degrading activities of the isolatedPL8domainof
Hyl arewell documented, both biochemically and structurally (11,
12). The hyaluronan binding activity of the putative N-terminal
CBM, however, is only hypothetical. To examine this, we cloned
the gene fragment encoding the putative CBM, here called
SpCBM70, and recombinantly produced this independent mod-
ule in Escherichia coli and purified it for characterization.
We initially screenedSpCBM70 for carbohydrate bindingusing
NGL arrays representing 492 distinct potential glycan receptors.
SpCBM70 interacted only with a single glycan on the array, a
14-mer fragment of hyaluronan (Fig. 1A). To examine further its
specificity, we used a focused GAG oligosaccharide microarray
that comprises NGL probes derived from size-defined oligosac-
charide fractions (ranging from 4-mers to 18-mers) of different
types of GAG polysaccharides: hyaluronan; chondroitin sulfates
CSA, CSB, and CSC; heparan sulfate; and heparin. Among these
were6-, 12-, 16-, and18-mer fragments of hyaluronan. Substantial
binding of SpCBM70 was observed to 12-mer and larger frag-
ments of hyaluronan (Fig. 1A, inset). Binding to hyaluronan was
further confirmed by qualitative affinity electrophoresis, which
revealed a strong reduction in the mobility of SpCBM70 in gels
polymerized with hyaluronan (Fig. 1B).
Using ITC, we quantified the binding of SpCBM70 to hyalu-
ronan and hyaluronan fragments (Table 3). SpCBM70 dis-
played binding to a 4-mer fragment of hyaluronan; however,
the interactionwas tooweak to quantify by ITC and is generally
consistent with the lack of binding to this oligosaccharide on
the glycan microarrays. The binding of SpCBM70 to longer
fragments (5–7-mer) displayed a 1:1 stoichiometry and increas-
ing affinity with increasing fragment length, the highest affinity
being for the 7-mer at 3.5  0.2  105 M1. The enthalpic
contribution to binding decreased with chain length, whereas
the entropic contribution increased considerably with favor-
able entropic contributions to binding for the 6- and 7-mer
TABLE 2
X-ray data collection, processing, and SpCBM70 model refinement
statistics
The coordinates of SpCBM70 are available under the PDB accession code 4D0Q.
Bromide peak Native
Data collection statistics
Wavelength 0.91951 0.95371
Beamline CLS 08B1-1 CLS 08B1-1
Space group P21 P21
Resolution 34.0-1.30 (1.37-1.30)a 35.3-1.20 (1.26-1.20)
Cell dimension 34.4, 61.1, 35.3 34.4, 60.8, 35.5
, ,  (Å) 90.0, 94.0, 90.0 90.0, 95.5, 90.0
Rmerge 0.059 (0.435) 0.041 (0.393)
Completeness (%) 98.8 (97.6) 99.4 (96.2)
	I/	I
 22.2 (4.6) 26.7 (4.5)
Redundancy 7.6 (7.6) 7.3 (6.4)
Total reflections 335,981 370,567
Unique reflections 35,392 45,171
Refinement statistics
Rwork/Rfree (%) 12.7/15.9
Rootmean square deviations
Bond lengths (Å) 0.016
Bond angles (degrees) 1.630
Average B-factors (Å2)
Protein molecule 13.7
Solvent molecules 34.3
No. of atoms
Protein atoms 2668
Solvent atoms 307
Ramachandran statistics
Most favored (%) 97.3 (145)
Additional allowed (%) 2.7 (4)
Disallowed (%) 0 (0)
a Values in parentheses represent data for the highest resolution shell.
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fragments. The favorable changes in H and S for binding to
the 6- and 7-mer hyaluronan fragments are unusual for CBM
carbohydrate interactions, which usually display favorable H
values with partially offsetting unfavorable S values (15).
The interaction of SpCBM70 with hyaluronan was analyzed
with ITC by titrating the CBM into a solution of the dissolved
polysaccharide (Table 3). The concentration of the hyaluronan
was treated asmolar equivalents of a 6-mer, and this resulted in
an n value of 0.86. This corresponds to oneCBMbinding to every
7-merblockon thepolysaccharide, thus suggesting thepotential
for quite close packing ofCBMsonhyaluronan atmaximum load-
ing. The affinity was similar to that found for the 6- and 7-mer
hyaluronan fragments; however, theHandSvaluesweremark-
edly different and more consistent with what is typically seen for
CBM carbohydrate interactions. The increased affinity for longer
hyaluronan fragments combined with an increased number of
binding sites may explain why only longer hyaluronan oligosac-
charides were detected in themicroarray analysis.
SpCBM70, therefore, is indeed a functional CBM, the founding
memberofCBMfamily70, andrepresents the firstCBMknownto
specifically interact with a glycosaminoglycan. Modules with sig-
nificant amino acid sequence identity to SpCBM70, and therefore
additional members of CBM family 70, are found predominantly
inother streptococcal species.Theaminoacidsequence identityof
these other putative CBM70s with SpCBM70 is as low as 30%.
However, the observation that they are found in proteins anno-
tated as hyaluronidases or hyaluronate lyases suggests that speci-
ficity for hyaluronanmay predominate in CBM family 70.
Properties of the Hyl CBM Hyaluronan Binding Site—
Because it is the first hyaluronan-specific CBM we sought to
provide insight into themolecular basis of hyaluronan recogni-
tion through structural studies of SpCBM70. The CBM crystal-
lized in space group P21 with one proteinmolecule in the asym-
metric unit. An initial model of the protein was built using
phases provided by a bromide-optimized single anomalous dis-
persion experiment, and datawere collected to 1.3Å resolution.
The final model was built and refined using a native data set
collected to 1.2 Å resolution and comprises 161 residues. The
polypeptide adopts a -sandwich fold of opposing 5-stranded
antiparallel -sheets with a jelly roll topology (Fig. 2A). The
sandwich is slightly bowed, creating a groove that spans the
-sheet on the concave surface. Due to the common nature of
this fold, SpCBM70 displays similarity to a large number of
proteins; however, the most functionally relevant proteins with
which SpCBM70 displays structural identity are the -sand-
wich CBMs. Although they have insignificant amino acid
sequence identity with SpCBM70, the most structurally similar
CBMs are those in family 4, as typified by the -1,3-glucan
binding TmCBM4-2 from Thermotoga maritima (PDB entry
1GUI, root-mean-square-deviation of 1.98 Å as measured by
secondary structurematching over 126matched Cs (42)) (Fig.
FIGURE 1.Analyses of the glycan binding properties of SpCBM70. A, microarray analysis of SpCBM70 binding specificity. The screening glycanmicroarray of 492
lipid-linked probes, NGLs, and glycosylceramides (370 mammalian type) is the Glycosciences Array Set 32–39 described previously (21) (supplemental Table 1).
Binding signals are expressed as numerical scores, means of fluorescence intensities of duplicate values recorded at 5 fmol oligosaccharide probe/spot. The
error bars represent half of the difference between the two values. The inset shows microarray analyses with 25 lipid-linked GAG oligosaccharide probes.
Numerical scores of the binding signals are means of duplicate spots (with error bars) of oligosaccharide probes printed at 2 (light gray bars) and 7 (dark gray
bars) fmol/spot on nitrocellulose-coated glass slides.HA, CS,HS, andHP, hyaluronan, chondroitin sulfate, heparin sulfate, and heparin fragments, respectively.
B, native polyacrylamide gel electrophoresis analysis of SpCBM70 in the absence of hyaluronan (hyaluronan) andwith hyaluronanpresent in the gel at a final
concentration of 0.045% (w/v) (hyaluronan). C1, C2, and C3, the migration of three non-interacting control proteins.
TABLE 3
Isothermal titration calorimetry analysis of the SpCBM70 interaction with hyaluronan and hyaluronan fragments
Carbohydrate n Ka H S G
M1 kcal/mol cal/mol/K kcal/mol
Hyaluronan 4-mer 5 103
Hyaluronan 5-mer 1.12 0.00 0.7 0.1 105 7.7 0.3 8.2 1.1 6.6 0.1
Hyaluronan 6-mer 1.07 0.06 1.4 0.1 105 2.6 0.1 14.8 0.8 7.0 0.1
Hyaluronan 7-mer 0.96 0.01 3.5 0.2 105 2.4 0.1 17.3 0.5 7.6 0.1
Hyaluronana 0.86 0.02 1.3 0.1 105 12.9 1.0 20.0 3.4 7.0 0.1
a Polysaccharide concentration was calculated based on the molecular weight of a 6-mer fragment.
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2B). Despite conservation of the overall fold, the metal-binding
site found in the family 4 CBMs was not found in SpCBM70.
Notably, the carbohydrate-binding site of the CBM4s, which
is invariably present on the concave surface of one -sheet, is in
the same general location as the groove on the surface of
SpCBM70. This particular surface of SpCBM70 possesses both
a distinct positive charge and a high degree of conservationwith
other sequences that fall into CBM family 70 (Fig. 2, C and D).
Furthermore, amore detailed comparison of this surface region
in SpCBM70 with the binding site of TmCBM4-2 reveals the
conservation of a solvent-exposed surface tryptophan that in
TmCBM4-2 is known to be critical for sugar binding (Fig. 2E)
(42, 43). The complementarity of the electrostatic properties of
this groove with hyaluronan, the conservation of surface resi-
dues among family CBM70, and the specific conservation of
functionally important residues with CBM4 suggest that this
site on SpCBM70 is the hyaluronan-binding site. Indeed, based
on homology modeling, this site on SpCBM70 was also pro-
posed by Rigden and Jedrzejas (14) as a putative binding site.
Because we were unable to generate a structure of SpCBM70
in complex with a fragment of hyaluronan, to provide addi-
tional evidence for the location of the binding site, we mutated
the solvent-exposed tryptophan as well as basic residues in the
putative binding groove (Fig. 2E) to alanine and assessed the
binding of these mutants to hyaluronan by quantitative affinity
electrophoresis. The mutations R112A and R145A abrogated
binding, whereas the mutations W82A and K185A reduced
binding by 50-fold (Table 4). The mutations H116A and
K143A had more modest effects on affinity, reducing binding
by 10-fold. These results conclusively identify the hyaluro-
nan-binding site of SpCBM70 as residing in the groove that is
conserved with family 4 CBMs. Furthermore, the results sug-
gest that the recognition of hyaluronan involves the aromatic
amino acid side chain-carbohydrate interactions that are typi-
cal of protein-carbohydrate interactions and ubiquitous to
FIGURE 2. The structure of SpCBM70. A, schematic representation of the 1.2 Å resolution structure of SpCBM70 shown from two angles and with the
solvent-accessible surface shown in transparent gray (right). B, a structural overlap of SpCBM70 (transparent orange) with TmCBM4–2 (blue/yellow) from
Thermotoga maritima (PDB entry 1GUI). The -1,3-glucohexaose molecule bound to TmCBM4–2 is shown as green sticks, and the bound calcium is shown as
a green sphere. C, the solvent-accessible surface of SpCBM70 (shown from the same angle as in B) colored by electrostatic potential. D, the solvent-accessible
surface of SpCBM70 (shown from the same angle as in B) colored by conservation of the residues among similar modules from Streptococci (generated using
ConSurf (54)). E, detailed viewof the overlap of the putative SpCBM70hyaluronanbinding site (orange) with the-1,3-glucohexaose binding site in TmCBM4-2
(gray). Residues targeted for mutagenesis in SpCBM70 are shown as sticks and labeled.
TABLE 4
Characterization of SpCBM70 and mutants binding to hyaluronan by
affinity electrophoresis
SpCBM70 Relative Kd
WT 1a
W82A 54
R112A NBb
H116A 8
R145A NB
K143A 14
K185A 55
a The Kd determined by affinity electrophoresis using a 7-mer binding site, as esti-
mated from the ITC data, was 7.2 0.8 M, which corresponds to a Ka of 1.4
105 M1.
b NB, no binding.
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CBMs but also potentially electrostatic interactions, which are
probably common in protein-GAG interactions but generally
rare in protein-carbohydrate interactions.
The Solution Structure of Hyl—Due to their structural irreg-
ularity, large multimodular enzymes, such as Hyl, typically
resist crystallization, resulting in limited structural data relat-
ing the individual functions of compositemodules to the overall
conformation of the protein. In the case of Hyl, the evolving
model of Hyl architecture is that it possesses hyaluronan-bind-
ing activity through its N-terminal CBM70 and hyaluronan-
degrading activity in its C-terminal PL8 domain. How these
modular functions are spatially coordinated is unknown, and
given the surface presentation of the protein and its involve-
ment in the bacterium-host interaction, understanding the
function of Hyl is of considerable interest.
Despite extensive attempts, we were unable to crystallize
full-length Hyl, so we addressed the issue of determining a full-
length structure of this protein by an alternate approach. A Hyl
construct comprising residues 53–1007 (Fig. 3A) and thus lack-
ing the N-terminal secretion signal peptide and C-terminal
cell-wall anchoring motif was purified by immobilized metal
affinity chromatography and a final size exclusion chromatog-
raphy step. Identical concentrations of pure Hyl (1.0–10.8
mg/ml) were examined by DLS and SAXS to examine the solu-
tion conformation of the full-length protein. Analysis by DLS
revealed what appeared to be a single protein population com-
prising99.8% of the sample by mass with a molecular mass of
150 kDa, a radius of50 Å, and a polydispersity of15–20%
(Table 5). Consistent with the DLS results, the scattering pro-
files obtained for a range of Hyl concentrations were character-
istic ofmonodisperse samples and indicated that increasing the
protein concentrations does not result in significant aggrega-
tion (Fig. 3B). Themolecularmass and radius ofRg of145 kDa
and47 Å, respectively, were in good agreement with the val-
ues determined by DLS, and the average particle density was
0.88 g/cm3 (Table 6).
Given these parameters, we approacheddetermination of the
full-length protein conformation by analysis of the SAXS data.
Tenmodels were generated for each concentration ofHyl using
the ab initio bead-modeling program DAMMIF. The averaged

(DAMMIF) values for each ensemble of 10 models ranged from
1.3 to 1.9 with normalized spatial discrepancies between 0.5
and 0.8 (Table 6). The overall shape is an “L”, with the lower
limb of the L representing a larger lobe of the molecule (Fig.
3C).
To generate pseudoatomic modules using the SAXS data
with our high resolution SpCBM70 structure and existing
structures of the PL8 domain, we had to complete the structural
coverage of the modules in Hyl because a structure of the70-
amino acid linker module has not been determined. This mod-
ule displays 40% amino acid sequence identity with the analo-
gous module in the structure of the S. agalactiaeHyl homolog,
allowing us to model the linker module using Phyre2 (44) with
the linker module of S. agalactiae Hyl as a template (Fig. 3D).
This resulted in a small compact structure with an Ig-like fold
(Fig. 3E). Using the structures of the three modules/domains,
we used both manual rigid body modeling by fitting the struc-
tures into the ab initio envelopes (Fig. 3F) and automated rigid
bodymodeling using the programBUNCH (not shown) to gen-
erate pseudoatomic models. Both approaches failed to achieve

 values better than5–6, thus indicating unsatisfactorymod-
els. Plots of q4 versus I(q)q4 do not plateau in the Porod-Debye
region (Fig. 3G), suggesting potential conformational heteroge-
neity (45), leading us to attempt to model the SAXS data using
the ensemble optimization method (results not shown); how-
ever, this failed to significantly reduce the 
 values.
In the absence of any evidence of protein aggregation, the
disagreement between the rigid bodymodels and the scattering
data suggested that the Hyl protein was present in solution as a
mixture of oligomeric states. This was supported by several
observations in the DLS and SAXS data. Both the DLS and
SAXS data gave similar molecular masses that were30–35%
higher than the expectedmolecularmass and thus outside of an
acceptable 10% error limit. The particle densities determined
from the SAXS data were also lower than anticipated for an
average globular protein, as exemplified by ourmeasurement of
1.1 g/cm3 for BSA, indicating that the measured Porod vol-
ume of the particles in solution is significantly larger than
expected for a protein of 110.6 kDa. Finally, the Rg values deter-
mined by SAXS appeared to increase with protein concentra-
tion. These observations are most consistent with Hyl existing
in a monomer/dimer equilibrium, with the presence of the
dimer species driving up the apparentmolecularmass, decreas-
ing the apparent particle density, and altering the apparentRg as
the equilibrium shifts in response to protein concentration.
To take into account the potential monomer/dimer equilib-
rium of Hyl in solution and provide insight into the conforma-
tion of the protein, we used the program SASREF7MX, which
combines rigid body modeling using the composite domains of
a protein with modeling mixtures of oligomeric states. In this
approach, we used SASREF7MX to model Hyl by treating it as
an equilibriumbetweenmonomeric and dimeric states, where the
conformationof themonomer is identical to thatof themonomers
comprising the dimer andwhere the dimer has P2 symmetry. The
polypeptide itself was modeled as three separate rigid bodies:
SpCBM70, the linker module, and the PL8 domain. Thus, all
polypeptide conformations from a single SASREF7MX run,
whether they are in themonomeric or dimeric species, are iden-
tical reconstructions, yielding a single model of a monomer, a
single model of a dimer of these monomers, a measure of the
fraction of associated volume for this dimer, and a 
 value rep-
resenting the quality of the model. Because this approach can
sometimes result in ambiguous reconstructions, we utilized
the maximum distance linking the modules/domains as con-
straints (46). To further enable our ability to recognize
potentially ambiguous or outlying reconstructions, we also
ran SASREF7MX 30 times for each concentration of Hyl from
1.0 to 2.7 mg/ml. Each resulting model was separately analyzed
with the program OLIGOMER to independently assess the
fractions of associated volumes and 
 values.
Overall, the 
 values fromSASREF7MXandOLIGOMER for
this pool of 120 models varied from 1.3 to 3.1, depending on
the protein sample, and thus the results were substantially
improved by considering Hyl as a mixture of oligomers in solu-
tion (Table 7). The volumes of the associated fractions deter-
mined by SASREF7MX and OLIGOMER were in good agree-
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ment and ranged from 30 to 40% (Table 7). Consistent with
this, an analysis of themonomer/dimer fraction in theDLS data
using typical expected radii for a globular monomer of 110.6
kDa (44-Å radius) and for the dimer of 221.2 kDa (60-Å radius)
gave dimer fractions of35% (Table 5). Based on conversion of
themonomer/dimer fractions to equilibrium concentrations of
monomer and dimer for Hyl in solution, and using the general
equilibrium equation Kd  [monomer]2/[dimer], this equates
to Kd values of43 M from the SAXS data and37 M from
the DLS data.
Of the 120 total models, 40 were rejected as likely to be
ambiguous reconstructions on the basis of having outlying 

values (2.0 from SASREF7MX) relative to the best obtained

 values. Notably, the 40 rejected models displayed quite
random dimer organizations and monomer conformations
(not shown). In contrast, the resulting 80models clearly divided
into two populations, revealing two discreet minima in the
modeling process that were reproducible over all of the protein
concentrations analyzed. Within a population, the dimer
arrangement and conformation of the monomers comprising
the dimers were not significantly different, whereas the overall

 values for a single model were excellent, suggesting that the
population actually represents a single predominant species
that does not display overt flexibility. A comparison between
the populations revealed a different dimer arrangement and
subtle differences in themonomer conformation. The two pop-
ulations occurred at roughly equal frequency in the 80 models.
On the basis of these results, we propose that each population
resulting from our multiple SASREF7MX analyses represents a
single possible Hyl monomer and corresponding dimer of the
monomers in solution. To represent the best two possiblemon-
omer/dimermodels, we chose onemodel from each population
giving the best SASREF7MX andOLIGOMER fits to the exper-
imental data (
 values of1.3; Fig. 4) and will refer to them as
models A and B. An examination of themonomers inmodels A
and B shows their similar overall extended shapes (Fig. 5,A and
B). Although the ab initio DAMMIF models do not represent
the mixture of Hyl species present in solution, they do approx-
imate the predominating monomeric species. A comparison of
the DAMMIF model with the A and B monomers revealed
them to agree well with the ab initio shapes; however, the A
monomer gave a visually better fit because the “kink” in the ab
initio shape fits the position of the linker module in this mono-
mer but does not for the B monomer (Fig. 5C).
A comparison of A and B dimers shows they share the
splayed CBM70 linker arms and that they associate at the PL8
domain (Fig. 5,D and E). To provide additional general support
for the dimerization of Hyl at its PL8 domain, we also used DLS
to study the solution properties of the isolated PL8 domain
(Table 5), our construct of which was based on the reported
domain boundaries used for structural studies of this polypep-
tide (11, 12). At all of the analyzed concentrations of PL8, the
samples showed low polydispersity and thus an absence of sig-
nificant aggregation. The apparent molecular mass was sub-
TABLE 5
Characterization of Hyl and its PL8 catalytic domain in solution by dynamic light scattering
Concentration Radius Polydispersity Mass
Percentage
of mass
Percentage of
associated fraction
mg/ml Å % kDa % %
Hyl
10.8 52.4 1.9 14.7 3.3 163 13 99.9 43.0
5.4 51.3 1.1 20.5 6.0 154 8 99.8 36.4
2.7 50.8 0.8 16.9 4.7 151 6 100.0 33.5
1.5 49.7 1.1 24.5 4.8 143 7 99.9 27.4
1.35 51.0 1.5 14.9 2.3 153 11 99.8 34.7
1.0 50.8 1.8 22.7 5.3 151 13 100.0 33.5
PL8
10.9 45.8 2.0 16.0 7.2 118 11 100.0 39.1
5.5 43.5 1.7 14.4 7.9 105 10 100.0 24.3
2.7 42.9 1.7 17.4 4.4 102 10 100.0 20.8
1.4 42.0 0.8 14.9 3.7 97 5 100.0 15.6
TABLE 6
Characterization of Hyl by small angle x-ray scattering
Concentration
Molecular
massa Rg (Guinier) Rg (GNOM) Dmax
Porod
volume
Particle
densityb
Ab initiomodeling
 (DAMMIF)c NSDd
mg/ml kDa Å Å Å Å3 g/cm3
Hyl 110.6e
10.80 146.2 48.2 1.0 49.5 170.5 211,709 0.87 1.93 0.23 0.66 0.02
5.40 143.6 48.4 1.4 49.7 170.1 206,944 0.89 1.60 0.12 0.68 0.02
2.70 149.9 46.7 1.2 48.2 165.6 211,245 0.87 1.64 0.01 0.80 0.04
1.50 155.4 47.2 0.6 48.1 166.6 220,516 0.83 1.43 0.01 0.64 0.02
1.35 134.9 44.7 3.5 46.6 158.1 193,604 0.95 1.44 0.01 0.73 0.03
1.00 144.7 45.1 2.0 46.8 159.5 207,955 0.88 1.32 0.01 0.54 0.06
BSA 66.4e
1.00 66.5 29.1 0.9 28.8 81 102,486 1.08 NAf NA
a Calculated by the method of Fischer et al. (55).
b Calculated by the method of Rambo et al. (45), based on a monomeric solution.
c Average of 
 values determined for the 10 models calculated by the DAMMIF ab initiomodelling procedure (35).
d Normalized spatial discrepancies averaged for the 10 models calculated by the DAMMIF ab initiomodeling procedure (36).
e Theoretical molecular masses calculated by primary sequence (20).
f NA, not applicable.
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stantially higher than the expected 82 kDa for the recombinant
protein, and both this parameter and the measured radius
showed a strong dependence on the protein concentration.
These features are consistent with a monomer/dimer equilib-
rium with an associated fraction similar to that calculated for
Hyl by both DLS and SAXS (Table 5). The Kd of dimerization
calculated based on estimated equilibrium concentrations is
180M.The propensity for the PL8 domain to dimerize is less
than that for Hyl, which may be due to the truncation of PL8,
but, overall, does provide support to the model that Hyl
dimerizes via association of the PL8 domain.
Overall, like the monomers, the dimers share highly similar
overall shapes, probably explaining why the rigid body recon-
structions converged on both models with equal frequency. In
the A and B dimers, the differing orientations of the PL8
domains in the monomers result in the generation of different
FIGURE 3.Modular properties and initial SAXS analysis of full-length Hyl. A, schematic of themodular architecture of Hyl. The - and -catalytic domains
constitute the PL8 domain. B, SAXS scattering profiles of Hyl, protein concentrations: 10.80 (red), 5.40 (yellow), 2.70 (blue), 1.50 (green), 1.35 (black), and 1.00
mg/ml (purple). C, DAMAVER averaged shape of 10 independent DAMMIF-generated envelopes of Hyl using the data collected on the 1.0 mg/ml sample. D,
alignment of the linkermodule fromHyl with the similarmodule from the Streptococcus agalactiaeHyl (SaHyl). E, Phyre2-generatedmodel using the structure
of the SaHyl linker domain as a template. F, the composite modules of Hyl (CBM (blue), linker (yellow), -catalytic domain (purple), and -catalytic domain
(green)) manually placed into the DAMMIF envelope. G, Porod-Debye plots of the SAXS data for Hyl. A, q4I(q) versus q4 plot for Hyl at 10.80 (red), 5.40 (yellow),
2.70 (blue), 2.4 (green), 1.35 (black), and 1.00 mg/ml (purple).
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dimerization interfaces in the PL8 domain. For more detailed
potential insight into the most likely dimerization interface, we
examined the crystal packing of the PL8 domain in the several
space groups for which a structure has been solved. A compar-
ison of the PL8 domain crystal packing in space group C2 (PDB
entry 2BRV)with the potential A and B dimers shows themajor
interfaces in the crystal packing to roughly represent both
observed dimerization interfaces in the SAXS structures (Fig.
6). This suggests that either dimerization interface in the SAXS
structure is possible, because there does indeed appear to be a
propensity for these sites on the protein to interact. However, it
is unlikely that both possible dimers form in solution. Although
we are unable to discriminate conclusively between the two
possible dimers, we favor the A dimer as the most plausible on
the basis of the observation that the A monomer displays a
substantially better match to the ab initio reconstructions of
Hyl with DAMMIF. Nevertheless, although the arrangements
of the core PL8 domain differ in the A and B dimers, the cata-
TABLE 7
Summary of SAXS-basedmonomer-dimer modeling of Hyl
Values represent the averages and S.D. of 30 independent SASREF7MX runs.
Concentration
SASREF7MX Oligomer
Average  Best 
Average associated
fraction Average  Best 
Average associated
fraction
mg/ml % %
2.70 1.37 0.05 1.31 33.2 1.4 2.21 0.57 1.59 36.5 1.2
1.50 1.33 0.02 1.32 35.9 0.8 1.62 0.19 1.47 39.9 0.8
1.35 1.42 0.04 1.39 26.5 1.7 2.34 0.47 2.25 27.9 5.4
1.00 1.26 0.01 1.25 29.8 1.4 1.40 0.13 1.31 33.1 1.3
FIGURE 4. SASREFMX and OLIGOMER fits of monomer dimer populations. A, SASREF7MX fit for best model of population A; B, OLIGOMER fit for best
model of population A; C, SASREF7MX fit for best model of population B; D, OLIGOMER fit for best model of population B. Models were generated with
SASREF7MX for Hyl at 1.00 mg/ml.
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lytic sites are oriented in roughly the same overall positions in
space, whereas the hyaluronan binding sites of the CBM are
positioned almost identically (Figs. 4G and 5F). This indicates
that although we cannot conclusively discriminate between the
two dimer possibilities, the interpretation of function based on
these models is the same overall.
DISCUSSION
The surface of S. pneumoniae is a complex landscape ofmac-
romolecules that, inmany cases, help tomediate the interaction
of the bacterium with the host. Among these molecules
involved in the bacterium-host interaction are a wide variety of
proteins that are covalently and non-covalently attached to the
bacterial surface (47, 48). Carbohydrate-active enzymes are
well represented among these proteins and are often associated
with pneumococcal virulence, as is the case with Hyl. A com-
mon property of the surface-attached pneumococcal enzymes
is theirmultimodularity, but the structures and functions of the
modules comprising these important enzymes are not well
studied.Of these enzymes, at present, only the surface-attached
enzyme SpuA and the secreted family 98 blood group anti-
gen-specific glycoside hydrolases (GH98) have been conclu-
sively demonstrated to have CBMs (49–51). In SpuA, one of
the CBM41 modules closes over the active site, aiding
directly in substrate recognition, whereas a second module is
oriented away from the active site and cell surface to presumably
function in adherence to glycogen (52). In theGH98 enzymes, the
CBMsareorientedaway fromtheactivesiteandprobably function
to target these soluble enzymes to glycans on host-cell surfaces
(51).
FIGURE 5. SAXS-based rigid body modeling of Hyl as an oligomeric mixture. A, model of the Hyl monomer present in population A generated by
SASREF7MX rigid body modeling of Hyl as a three-module protein in a monomer/dimer equilibrium. B, as in A but the Hyl monomer present in population B.
C, monomers of population A (purple) and population B (yellow) overlapped with the DAMMIF-generated envelopes of Hyl (1.0 mg/ml) using SUPCOMB. The
monomers in A and B are shown in the same orientation as they are in the overlapped view in C.D and E, dimer structures of populations A and B, respectively,
shown fromsimilar sideand top views. Themodules are coloredas follows: CBM(blue), linker (yellow),-catalyticdomain (purple), and-catalyticdomain (green).
TheN andC termini are labeled for reference. F andG, top views of the dimer structures of populations A and B, respectively, as solvent-accessible surface areas
with the binding sites of the CBMs colored purple and the active site of the PL8 domain colored purple and with a bound substrate (green sticks; modeled from
the structure of the PL8 domain in complex with a 4-mer fragment of hyaluronan; PDB entry 1LXK).
SpCBM70 Structure and Hyaluronan Binding Properties
27274 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 39•SEPTEMBER 26, 2014
Here we have shown that Hyl also possesses a CBM, now
classified into CBM family 70, that is hyaluronan-specific.
Based on our SAXS analysis of Hyl, we propose two possible
modes of surface presentation of this enzyme: as a monomer or
as a dimer (Fig. 7). In both cases, the presentation is constrained
by the orientation of the C-terminal bacterial surface attach-
ment point (LPXTG motif), resulting in the CBM probably
beingmost distal from the bacterial surface with its binding site
oriented out. The catalytic site would also be generally oriented
away from the bacterial surface. Unlike with SpuA, there is no
evidence to suggest that that CBM and the catalytic site of Hyl
directly cooperate in substrate recognition. However, the co-
orientation of the functional sites in the enzyme is consistent
with the surface presentation of the enzyme and its role in a
partitioned system of two interacting media: the bacterial cell
surface and extracellular matrix. This is clearly different from
the CBM presentation in the GH98 enzymes, where their solu-
ble deployment appears to allow somewhat randomorientation
of the CBM binding sites relative to the catalytic sites.
A remarkable feature and novel observation of Hyl is its
potential to dimerize.We acknowledge that there is presently a
lack of evidence that Hyl is present on the surface of the bacte-
rium as a dimer. However, we have shown that purified Hyl has
a relatively strong propensity to dimerize in solution. This
dimerization occurs in such a way that the C termini are ideally
co-oriented to attach the dimer to the bacterial cell surface
while leaving the functional sites in bothmonomers positioned
away from the bacterial surface. Furthermore, the conditions
wheremonomers are being oriented for attachment to the bac-
terial surface during export could aid in driving dimer forma-
tion by reducing the entropic costs of self-association. Thus, the
circumstances would seem to favor the presentation of Hyl as
dimers on the bacterial surface. Alternatively, Hyl is also found
as a soluble protein, and our evidence is in favor of its dimeriza-
tion under these conditions. In either case (dimerization on the
surface or in solution), the dimer adopts a “crablike” shape with
functional implications (Fig. 7).
Consistent with most CBM-carbohydrate interactions, the
affinity of SpCBM70 for hyaluronan was somewhat modest,
with aKa of1 105 M1 (Kd10M). Clustering and co-ori-
entation of the CBMs by enzyme dimerization, on the bacterial
surface or in solution, would probably promote avidity effects
in recognizing hyaluronan aggregated in the extracellular
matrix. Indeed, the LewisY antigen active GH98 from S. pneu-
moniae has three family 47 CBMs with inherently low individ-
ual affinities; however, their tandem presentation takes advan-
tage of avidity to effect an overall increase in apparent affinity
(50). The dimerization of a CBM-containing enzyme is an ele-
gant potential solution to exploiting CBM avidity.
Hyl is a processive enzyme first making an endolytic cut and
then processing toward the non-reducing end and releasing a
disaccharide product with a 4,5-unsaturated non-reducing end
D-glucuronic acid. Strikingly, the polarity of the PL8 domain
catalytic sites in the dimer of population A (Fig. 5, B and F) is
such that the reducing end of a hyaluronan chain would enter
from the top of the dimer (on the CBM side), and the product
would be released from the bottom of the dimer as the polymer
feeds through the active site in a processive fashion (Fig. 7B). In
the case of a cell surface-attached dimer, this evokes a model
whereby the CBM arms grasp hyaluronan in the extracellular
matrix, adhering the bacterium to the hyaluronan, the chains
are fed through the PL8 active sites, and then disaccharide
product is released right at the bacterial surface. This could
optimize transport of the product by a membrane-embedded
PTS transporter that is specific for the degradation products of
Hyl (10). Alternatively, for soluble Hyl dimer, the conformation
is suggestive of a similar model, but the disaccharide products
would be released away from the area of binding and degrada-
tion on the extracellular matrix, thus potentially making the
soluble product more accessible to the bacterium for uptake.
As hypothesized byRigden and Jedrzejas (53), we have shown
that pneumococcal Hyl has a highly specific hyaluronan-bind-
ing CBM. Through SAXS analysis of this multimodular
FIGURE 6. Comparison of the SAXS-based solution dimers of Hys (CBM
and linker not shown for clarity) with dimers of the PL8 domain gener-
atedbycrystallographicpacking in theC2crystal form(PDBentry1BRV).
A, the dimer of the PL8 domain in population A (gray) overlapped with one
crystallographic dimer of the PL8 domain (blue). B, the dimer of the PL8
domain in population B (gray) overlappedwith the alternate crystallographic
dimer of the PL8 domain (blue).
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enzyme, we have provided evidence that this protein adopts a
conformation and quaternary structure that appear to be opti-
mized for cell surface presentation and coordination of hyalu-
ronan binding by the CBM with degradation by the PL8 cata-
lytic module. Overall, these results enhance our understanding
of the possible surface presentation and role of such architec-
turally complex and multifunctional enzymes in the host-
pathogen interaction.
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